Wei-xuan Lu
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
Papers in
-
- Pulmonary Hypertension Research and Treatments 4
- Chronic Obstructive Pulmonary Disease (COPD) Research 2
-
- Asthma and respiratory diseases 2
- Nitric Oxide and Endothelin Effects 2
- Co-authors
- Chen Wang (6 shared papers)Lirong Liang (3 shared papers)Ying H. Shen (2 shared papers)Kewu Huang (3 shared papers)Yuanhua Yang (3 shared papers)Xian-sheng Cheng (3 shared papers)Zhaozhong Cheng (3 shared papers)Zhenguo Zhai (3 shared papers)
- Journals
- Journal of Applied Physiology (2 papers)CHEST Journal (1 paper)Pulmonary Pharmacology & Therapeutics (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)Fuel (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Wei-xuan Lu
22 papers receiving 316 citations
Peers
Comparison fields: 5 of 54
- Internal Medicine 185
- Cardiology and Cardiovascular Medicine 124
- Critical Care and Intensive Care Medicine 14
- Emergency Medical Services 18
- Pulmonary and Respiratory Medicine 60
Countries citing papers authored by Wei-xuan Lu
This map shows the geographic impact of Wei-xuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-xuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-xuan Lu more than expected).
Fields of papers citing papers by Wei-xuan Lu
This network shows the impact of papers produced by Wei-xuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-xuan Lu. The network helps show where Wei-xuan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei-xuan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 186 | |
| 2 | 1998 | 35 | |
| 3 | 2009 | 21 | |
| 4 | 2024 | 14 | |
| 5 | [The use of Juniper's asthma quality of life questionnaire in Chinese asthmatics]. | 2003 | 11 |
| 6 | [Application of St George's respiratory questionnaire in evaluating the life quality of Chinese patients with chronic obstructive pulmonary disease]. | 2003 | 10 |
| 7 | 1998 | 6 | |
| 8 | 2013 | 5 | |
| 9 | [Clinical features of pulmonary involvement in patients with microscopic polyangiitis]. | 2011 | 5 |
| 10 | [The clinical analysis of pulmonary arterial hypertension in connective tissue disease]. | 2006 | 5 |
| 11 | 1997 | 5 | |
| 12 | 1998 | 4 | |
| 13 | 2012 | 4 | |
| 14 | [Simvastatin prevents the development of pulmonary hypertension in the rats through reduction of inflammation]. | 2009 | 4 |
| 15 | [The change of pulmonary surfactant associated protein A in acute pulmonary embolism]. | 2005 | 3 |
| 16 | 2015 | 2 | |
| 17 | [Thrombosis diseases and lung cancer]. | 2000 | 2 |
| 18 | [Pulmonary embolism in cancer: clinical analysis of 60 cases]. | 2009 | 2 |
| 19 | [Protective effects of rosiglitazone intervention on monocrotaline-induced pulmonary arterial hypertension in rats and related inflammatory mechanisms]. | 2012 | 2 |
| 20 | [The low molecular weight heparin on rat pulmonary surfactant associated protein A of acute pulmonary embolism]. | 2007 | 1 |
About Wei-xuan Lu
Wei-xuan Lu is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Internal Medicine, Endocrine and Autonomic Systems and Catalysis, having authored 22 papers that have together received 329 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Asthma and respiratory diseases (2 papers), Nitric Oxide and Endothelin Effects (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers), Gas Sensing Nanomaterials and Sensors (1 paper), Catalysis and Oxidation Reactions (1 paper) and Catalytic Processes in Materials Science (1 paper). The work is most often cited by research in Internal Medicine (185 citations), Cardiology and Cardiovascular Medicine (124 citations), Critical Care and Intensive Care Medicine (14 citations), Emergency Medical Services (18 citations) and Pulmonary and Respiratory Medicine (60 citations). Wei-xuan Lu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Chen Wang, Lirong Liang, Ying H. Shen, Kewu Huang, Yuanhua Yang, Xian-sheng Cheng, Zhaozhong Cheng, Zhenguo Zhai, Huaping Dai and Qi Wu. Their work appears in journals such as Journal of Applied Physiology, CHEST Journal, Pulmonary Pharmacology & Therapeutics, American Journal of Respiratory and Critical Care Medicine and Fuel.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.